Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-05-29
2007-05-29
Wax, Robert A. (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S856000, C530S350000, C424S542000
Reexamination Certificate
active
09938114
ABSTRACT:
This invention features an antithrombosis enzyme extracted and purified from the snake venom of Southern-Anhui Agkistrodon acutus and pharmaceutical uses thereof.
REFERENCES:
patent: 4017012 (1977-04-01), Brock
patent: 5066592 (1991-11-01), Huang et al.
patent: 5071773 (1991-12-01), Evans et al.
patent: 5196403 (1993-03-01), Maraganore et al.
patent: 5242810 (1993-09-01), Maraganore et al.
patent: 5342830 (1994-08-01), Scarborough
patent: 5344783 (1994-09-01), Scarborough et al.
patent: 5453370 (1995-09-01), Triplett et al.
patent: 5523292 (1996-06-01), Schwartz et al.
patent: 5686571 (1997-11-01), Scarborough et al.
patent: 5733738 (1998-03-01), Niman
patent: WO 89/04489 (1989-05-01), None
patent: WO 91/12258 (1991-08-01), None
patent: WO 93/09236 (1993-05-01), None
Atoda et al. Blood Coagulation Factor IX—Binding Protein from the Venom of Trimeresurus flavoviridis: Purification and Characterization. J. Biochem. 118(5): 965-973. 1995.
Robyt, J.F. “Biochemical Techniques: Theory and Practice”, Waveland Press, Prostpect Heights, IL, 1987 p. 300.
Bajwa et al., “Fibrinolytic enzyme(s) in western diamond-back rattlesnake (crotalus atrox) venom.”Toxicon18:285-290 (1980).
Bayer et al., “The Avidin-Blotin Complex in Affinity Cytochemistry,”Methods in Enzymology62:308-319 (1979).
Bullock et al., “Techniques in Immunocytochemistry,” Academic Press, Orlando, FL: vol. 1(1982), vol. 2(1983), vol. 3(1985) (Table fo Contents Only).
Campbell,Monoclonal Antibody Technology: Laboratory Techniques in Biochemistry and Molecular Biology,vol. 13, Elsevier Science Publishers, Amsterdam, The Netherlands (1984) (Table of Contents Only).
Capecchi, “High Efficiency Transformation by Directo Microinjection of DNA into Cultured Mammalian Cells,”Cell22:479-488 (1980).
Chard,An Introduction to Radioimmunoassay and Related Techniques,Elsevier Science Publishers, Amsterdam, The Neverlands (1986) (Table of Contents Only).
Chen and Okayama, “High-Efficiency Transformation of Mammalian Cells by Plasmid DNA”,Molecular and Cellular Biology7(8):2745-2752 (1987).
Chu et al., “Electroporation for the efficient transfection of mammalian cells with DNA,”Nucleic Acids Research15:1311-1326 (1987).
Curiel et al., “Gene Transfer to Respiratory Epithelial Cells via the Receptor-mediated Endocytosis Pathway,”Am J. Respir. Cell. Mol. Biol.6(247-252 (1992).
Derborg et al., “Ch. 10—The chemistry and standardization of allergens,” inHandbook of Experimental immunology—vol. I: Immunochemistry,4thEd., edited by Weir et al., Blackwell Scientific Publications, Oxford, Engalnd, pp. 10.1-10.28 (1986).
Engvali and Perlmann, “Enzyme-Linked Immunosorbent Assay, ELISA. III. Quantitation of Specific Antibodies by Enzyme-Labeled Anti-Immunoglobulin in Antigen-Coated Tubes,”J. Immunology109:129-135 (1972).
Feigner and Ringold, “Cationic liposome-mediated transfection,”Nature,337:387-388 (1989).
Feigner et al., “Lipofection: A Highly Efficient, Lipid-mediated DNA-transfection Procedure,”Proc. Natl. Acad. Sci.USA 84:7413-7417 (1987).
Ferrari et al., “An in Vivo Model of Somatic Cell Gene Therapy for Human Severe Combined Immunodeficienty,”Science251:1363-1366 (1991).
Fingl and Woodbury, “Chapter 1—General Principles,” inThe Pharmacological Basis of Therapeutics5thedition, Goodman and Gilman editors, MacMillan Publishing Co., Inc., New York, pp. 1-46 (1975).
Gennaro (editor),Remington's Pharmaceutical Sciences(1990) (Table of Contents Only).
Goding, “Conjugation of Antibodies with Fluorochromes: Modifications to the Standard Methods,”J. Immunological Methods13:215-226 (1976).
Hurby et al., “Applications of Synthetic Peptides: Antisense Peptieds,” inSynthetic Peptides: A suer's Guide,edited by Gregory A. Grant, W.H. Freeman, NY, pp. 289-307 (1992).
Kasprzak et al., “Location of a Contract Site Between Actin and Myosin ing the Three-Dimensional Structure of the Acto-S1 Complex, ”Biochemistry28:9230-9238 (1989).
Laemmli, “Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4,”Nature227:680-686 (1970).
Lutz et al., “The Distribution of Two hnRnP—Associated Proteins Defined by a Monoclonal Antibody is Altered in Heat-Shocked HeLa Cells,”Experimental Cell Research175:109-124 (1988).
Matsuzaki et al., “cDNA cloning of /X/X-PB, a heterogeneous two-chain anticoagulant protein from snake venom,”Biochem Biophys. Res. Com.220(2):382-387 (1996).
Miller, “Human Gene Therapy Comes of Age,”Nature357:455-460 (1992).
Morita et al., “Structure and functions of coagulation factor IX/factorx-binding protein isolated from the venom of Trimeresurus flavovridis,”Natural Toxins IIpp. 187-196 (1996).
Mulligan, “The Basic science of Gene Therapy,”Science260:926-932 (1993).
St. Groth and Scheidegger, “Production of Monoclonal Antibodies: Strategy and Tactics,”J. Immunol. Methods35:1-21 (1980).
Sternberger et al., “The unlabeled Antibody Enzyme Method of Immunohistochemistry: Preparation and Properties of Soluble Antigen-Antibody Complex (Horseradish Peroxidase-Antihorseradish Perixodase) and its Use in Identification of Spirochetes,”J. Histochemistry and Cytochemistry18(5):315-333 (1970).
Tijssen,Practice and Theory of Enzyme Immunoassays: Laboratory Techniques in Biochemistry and Molecular Biology,vol. 15 Elsevier Science Publishers, Amsterdam, The Netherlands (1985 (Table of Contents Only).
Wilchek an Jakoby, “The Literature on Affinity Chromatography,”Methods in Enzymology34:3—10 (1974).
Yang et al., “In Vivo and In Vitro Gene Transfer to Mammalian Somatic Cells by Particle Bombardment,”Proc. Natl. Acad. Sci. USA87:9568-9572 (1990).
Chen Hui-Ran
Cheng Xin
Ding Jin-Guo
Huang Wan-Zhi
Kang Lian-Di
Hefei-Siu-Fung USTC Pharmaceutical Co., Ltd.
Mitra Rita
Wax Robert A.
Wise Michael J.
LandOfFree
Antithrombosis enzyme from the snake venom of agkistrodon... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antithrombosis enzyme from the snake venom of agkistrodon..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antithrombosis enzyme from the snake venom of agkistrodon... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3731448